Platinum Investment Management’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.82M | Buy |
290,836
+22,949
| +9% | +$302K | 0.25% | 39 |
|
|
2025
Q1 | $3.85M | Sell |
267,887
-102,391
| -28% | -$1.47M | 0.22% | 34 |
|
|
2024
Q4 | $6.2M | Sell |
370,278
-59,423
| -14% | -$995K | 0.36% | 30 |
|
|
2024
Q3 | $6.87M | Sell |
429,701
-66,194
| -13% | -$1.06M | 0.31% | 31 |
|
|
2024
Q2 | $4.48M | Buy |
495,895
+10,721
| +2% | +$96.8K | 0.18% | 41 |
|
|
2024
Q1 | $5.48M | Buy |
485,174
+104,091
| +27% | +$1.18M | 0.22% | 39 |
|
|
2023
Q4 | $3.03M | Buy |
381,083
+43,539
| +13% | +$347K | 0.12% | 68 |
|
|
2023
Q3 | $2.18M | Buy |
337,544
+165,919
| +97% | +$1.07M | 0.09% | 78 |
|
|
2023
Q2 | $1.06M | Buy |
+171,625
| New | +$1.06M | 0.04% | 97 |
|